SmartNuclide

Technology

Focus on developing the most innovative radiopharmaceuticals

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

06/02/2022

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

https://doi.org/10.2967/jnumed.120.248799